Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
Total Valuation
GoodRx Holdings has a market cap or net worth of $1.62B. The enterprise value is $1.88B.
Market Cap$1.62B
Enterprise Value$1.88B
Share Statistics
GoodRx Holdings has 102,468,710 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding102,468,710
Owned by Insiders11.18%
Owned by Institutions0.44%
Financial Efficiency
GoodRx Holdings’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.69%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)2.69%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee1.07M
Profits Per Employee22.21K
Employee Count738
Asset Turnover0.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GoodRx Holdings is 109.44. GoodRx Holdings’s PEG ratio is -0.17.
PE Ratio109.44
PS Ratio0.00
PB Ratio2.48
Price to Fair Value2.48
Price to FCF11.00K
Price to Operating Cash Flow11.00K
PEG Ratio-0.17
Income Statement
In the last 12 months, GoodRx Holdings had revenue of 792.32M and earned 16.39M in profits. Earnings per share was 0.12.
Revenue792.32M
Gross Profit744.11M
Operating Income65.85M
Pretax Income31.46M
Net Income16.39M
EBITDA153.92M
Earnings Per Share (EPS)0.12
Cash Flow
In the last 12 months, operating cash flow was 183.89M and capital expenditures -70.35M, giving a free cash flow of 113.55M billion.
Operating Cash Flow183.89M
Free Cash Flow113.55M
Free Cash Flow per Share1.11
Dividends & Yields
GoodRx Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.06
52-Week Price Change-34.55%
50-Day Moving Average4.52
200-Day Moving Average5.65
Relative Strength Index (RSI)46.49
Average Volume (3m)1.08M
Important Dates
GoodRx Holdings upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
GoodRx Holdings as a current ratio of 5.32, with Debt / Equity ratio of 7.82%
Current Ratio5.32
Quick Ratio5.32
Debt to Market Cap0.03
Net Debt to EBITDA-2.54
Interest Coverage Ratio1.24
Taxes
In the past 12 months, GoodRx Holdings has paid 15.07M in taxes.
Income Tax15.07M
Effective Tax Rate0.48
Enterprise Valuation
GoodRx Holdings EV to EBITDA ratio is 9.11, with an EV/FCF ratio of 8.60K.
EV to Sales1.77
EV to EBITDA9.11
EV to Free Cash Flow8.60K
EV to Operating Cash Flow8.60K
Balance Sheet
GoodRx Holdings has $448.35M in cash and marketable securities with $704.92M in debt, giving a net cash position of -$391.67M billion.
Cash & Marketable Securities$448.35M
Total Debt$704.92M
Net Cash-$391.67M
Net Cash Per Share-$3.82
Tangible Book Value Per Share$0.68
Margins
Gross margin is 89.76%, with operating margin of 8.31%, and net profit margin of 2.07%.
Gross Margin89.76%
Operating Margin8.31%
Pretax Margin3.97%
Net Profit Margin2.07%
EBITDA Margin19.43%
EBIT Margin10.65%
Analyst Forecast
The average price target for GoodRx Holdings is $6.68, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.68
Price Target Upside57.55% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast4.35%
EPS Growth Forecast―